CHIEF ACCOUNTING OFFICER at Compass Therapeutics, Inc. Buys $18,400 in Stock

Neil Lerner, who serves as CHIEF ACCOUNTING OFFICER at Compass Therapeutics, Inc. (CMPX), purchased 20,000 shares of the company's stock, according to a disclosure filed with the U.S. Securities and Exchange Commission.

The transaction was executed at a price of $0.92 per share, for a total value of approximately $18,400.

Insider transactions of this kind are publicly disclosed through Form 4 filings with the SEC, which must generally be submitted within two business days of the trade date.

Insider buying is sometimes viewed by investors as a signal of confidence in a company's prospects, though a single transaction does not necessarily indicate a broader trend.